JP7446619B2 - 輸送溶液によって間葉系幹細胞を輸送する方法および幹細胞を創傷に投与する方法 - Google Patents

輸送溶液によって間葉系幹細胞を輸送する方法および幹細胞を創傷に投与する方法 Download PDF

Info

Publication number
JP7446619B2
JP7446619B2 JP2020556307A JP2020556307A JP7446619B2 JP 7446619 B2 JP7446619 B2 JP 7446619B2 JP 2020556307 A JP2020556307 A JP 2020556307A JP 2020556307 A JP2020556307 A JP 2020556307A JP 7446619 B2 JP7446619 B2 JP 7446619B2
Authority
JP
Japan
Prior art keywords
cells
mesenchymal stem
stem cell
cell population
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020556307A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523883A (ja
JP2021523883A5 (cg-RX-API-DMAC7.html
Inventor
トアン タン ファン
ブライアン エム. フリード
Original Assignee
セルリサーチ コーポレイション プライベート リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by セルリサーチ コーポレイション プライベート リミテッド filed Critical セルリサーチ コーポレイション プライベート リミテッド
Publication of JP2021523883A publication Critical patent/JP2021523883A/ja
Publication of JP2021523883A5 publication Critical patent/JP2021523883A5/ja
Priority to JP2024023576A priority Critical patent/JP7804359B2/ja
Application granted granted Critical
Publication of JP7446619B2 publication Critical patent/JP7446619B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides or bases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Botany (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2020556307A 2018-04-09 2019-04-09 輸送溶液によって間葉系幹細胞を輸送する方法および幹細胞を創傷に投与する方法 Active JP7446619B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024023576A JP7804359B2 (ja) 2018-04-09 2024-02-20 輸送溶液によって間葉系幹細胞を輸送する方法および幹細胞を創傷に投与する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862655198P 2018-04-09 2018-04-09
US62/655,198 2018-04-09
PCT/SG2019/050197 WO2019199229A1 (en) 2018-04-09 2019-04-09 A method of transporting mesenchymal stem cells by means of a transporting solution and a method of administering stem cells to wounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024023576A Division JP7804359B2 (ja) 2018-04-09 2024-02-20 輸送溶液によって間葉系幹細胞を輸送する方法および幹細胞を創傷に投与する方法

Publications (3)

Publication Number Publication Date
JP2021523883A JP2021523883A (ja) 2021-09-09
JP2021523883A5 JP2021523883A5 (cg-RX-API-DMAC7.html) 2022-07-01
JP7446619B2 true JP7446619B2 (ja) 2024-03-11

Family

ID=68098812

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020556307A Active JP7446619B2 (ja) 2018-04-09 2019-04-09 輸送溶液によって間葉系幹細胞を輸送する方法および幹細胞を創傷に投与する方法
JP2024023576A Active JP7804359B2 (ja) 2018-04-09 2024-02-20 輸送溶液によって間葉系幹細胞を輸送する方法および幹細胞を創傷に投与する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024023576A Active JP7804359B2 (ja) 2018-04-09 2024-02-20 輸送溶液によって間葉系幹細胞を輸送する方法および幹細胞を創傷に投与する方法

Country Status (5)

Country Link
US (2) US11400119B2 (cg-RX-API-DMAC7.html)
EP (1) EP3772936A4 (cg-RX-API-DMAC7.html)
JP (2) JP7446619B2 (cg-RX-API-DMAC7.html)
AU (1) AU2019253009B2 (cg-RX-API-DMAC7.html)
WO (1) WO2019199229A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022552230A (ja) * 2019-10-08 2022-12-15 セルリサーチ コーポレイション プライベート リミテッド 間葉系幹細胞貯蔵または輸送製剤、およびその作製および使用方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114585255A (zh) * 2019-11-08 2022-06-03 博傲沃德株式会社 干细胞用冷藏保存液
DE102021105020A1 (de) * 2021-03-02 2022-09-08 Carl Zeiss Microscopy Gmbh Mikroskopiesystem und Verfahren zum Verarbeiten eines Mikroskopbildes
JPWO2022239556A1 (cg-RX-API-DMAC7.html) * 2021-05-11 2022-11-17

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008509699A (ja) 2004-08-16 2008-04-03 セルリサーチ コーポレイション ピーティイー リミテッド 臍帯羊膜からの幹/前駆細胞の単離

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101330935B (zh) 2005-10-21 2013-11-13 细胞研究私人有限公司 自脐带羊膜分离和培养干/祖细胞及其分化的细胞的应用
CN103356710A (zh) 2007-02-12 2013-10-23 人类起源公司 利用胎盘干细胞治疗炎性疾病
EP2268796A1 (en) 2008-03-17 2011-01-05 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Vectors and methods for generating vector-free induced pluripotent stem (ips) cells using site-specific recombination
EP2128245A1 (en) 2008-05-27 2009-12-02 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Generation of induced pluripotent stem (iPS) cells
WO2009155334A1 (en) * 2008-06-20 2009-12-23 Escape Therapeutics, Inc. Differentiation of mesenchymal stem cells into fibroblasts, compositions comprising mesenchymal stem cell-derived fibroblasts, and methods of using the same
GB0822246D0 (en) 2008-12-05 2009-01-14 Reneuron Ltd Composition
EP2218778A1 (en) 2009-02-16 2010-08-18 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Conversion of unipotent germline stem cells into pluripotent stem cells without exogenous factors
EP3142485B1 (en) 2014-05-12 2021-04-28 Roosterbio, Inc. Ready-to-print cells and integrated devices
WO2017096607A1 (zh) 2015-12-11 2017-06-15 郭镭 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法
TWI773693B (zh) 2016-10-05 2022-08-11 新加坡商細胞研究私人有限公司 從臍帶的羊膜分離間質幹細胞的方法、從臍帶的羊膜分離的間質幹細胞群以及用於從臍帶的羊膜分離間質幹細胞的細胞培養基

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008509699A (ja) 2004-08-16 2008-04-03 セルリサーチ コーポレイション ピーティイー リミテッド 臍帯羊膜からの幹/前駆細胞の単離

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J. Vis. Exp.,2017年,122,Article.e55224,<DOI:10.3791/55224>
日大医誌,2016年,75, [2],p.61-66

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022552230A (ja) * 2019-10-08 2022-12-15 セルリサーチ コーポレイション プライベート リミテッド 間葉系幹細胞貯蔵または輸送製剤、およびその作製および使用方法
JP7861268B2 (ja) 2019-10-08 2026-05-19 セルリサーチ コーポレイション プライベート リミテッド 間葉系幹細胞貯蔵または輸送製剤、およびその作製および使用方法

Also Published As

Publication number Publication date
AU2019253009A1 (en) 2020-10-15
US11998569B2 (en) 2024-06-04
JP2024059760A (ja) 2024-05-01
EP3772936A1 (en) 2021-02-17
WO2019199229A1 (en) 2019-10-17
JP7804359B2 (ja) 2026-01-22
JP2021523883A (ja) 2021-09-09
US11400119B2 (en) 2022-08-02
EP3772936A4 (en) 2022-01-05
US20190307805A1 (en) 2019-10-10
AU2019253009B2 (en) 2025-09-25
US20230047491A1 (en) 2023-02-16

Similar Documents

Publication Publication Date Title
US12344861B2 (en) Method of isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord, a mesenchymal stem cell population isolated from the amniotic membrane of the umbilical cord and a cell culture medium for isolating mesenchymal stem cells from the amniotic membrane of the umbilical cord
JP7804359B2 (ja) 輸送溶液によって間葉系幹細胞を輸送する方法および幹細胞を創傷に投与する方法
JP7861268B2 (ja) 間葉系幹細胞貯蔵または輸送製剤、およびその作製および使用方法
JP7541730B2 (ja) 間葉系幹細胞の創傷治癒特性を誘導するまたは改善する方法
US10104881B2 (en) Composition comprising plant-derived recombinant human serum albumin, lipids, and plant protein hydrolysates as active ingredients for cryopreservation of stem cells or primary cells
WO2019199230A1 (en) A method of transporting mesenchymal stem cells by means of a cell culture medium and a method of administering stem cells to wounds
RU2836320C1 (ru) Композиция для хранения или транспортировки мезенхимальных стволовых клеток и способы ее приготовления и применения
HK40004787B (en) A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium
HK40004787A (en) A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20210112

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210715

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20220407

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220408

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220408

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220603

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230426

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230720

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231025

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20231120

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240122

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240220

R150 Certificate of patent or registration of utility model

Ref document number: 7446619

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150